Lee EK - Search Results

1

Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6.

Yoshida A, Lee EK, Diehl JA. Yoshida A, et al. Among authors: lee ek. Cancer Res. 2016 May 15;76(10):2990-3002. doi: 10.1158/0008-5472.CAN-15-2931. Epub 2016 Mar 17. Cancer Res. 2016. PMID: 26988987 Free PMC article.

2

The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Lee EK, Lian Z, D'Andrea K, Letrero R, Sheng W, Liu S, Diehl JN, Pytel D, Barbash O, Schuchter L, Amaravaradi R, Xu X, Herlyn M, Nathanson KL, Diehl JA. Lee EK, et al. Mol Cell Biol. 2013 Nov;33(22):4422-33. doi: 10.1128/MCB.00706-13. Epub 2013 Sep 9. Mol Cell Biol. 2013. PMID: 24019069 Free PMC article.

3

FBXO4 loss facilitates carcinogen induced papilloma development in mice.

Lian Z, Lee EK, Bass AJ, Wong KK, Klein-Szanto AJ, Rustgi AK, Diehl JA. Lian Z, et al. Among authors: lee ek. Cancer Biol Ther. 2015;16(5):750-5. doi: 10.1080/15384047.2015.1026512. Cancer Biol Ther. 2015. PMID: 25801820 Free PMC article.

4

The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation.

Vaites LP, Lee EK, Lian Z, Barbash O, Roy D, Wasik M, Klein-Szanto AJ, Rustgi AK, Diehl JA. Vaites LP, et al. Among authors: lee ek. Mol Cell Biol. 2011 Nov;31(22):4513-23. doi: 10.1128/MCB.05733-11. Epub 2011 Sep 12. Mol Cell Biol. 2011. PMID: 21911473 Free PMC article.

5

Phosphorylation-dependent regulation of SCF(Fbx4) dimerization and activity involves a novel component, 14-3-3ɛ.

Barbash O, Lee EK, Diehl JA. Barbash O, et al. Among authors: lee ek. Oncogene. 2011 Apr 28;30(17):1995-2002. doi: 10.1038/onc.2010.584. Epub 2011 Jan 17. Oncogene. 2011. PMID: 21242966 Free PMC article.

6

ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis.

Vaites LP, Lian Z, Lee EK, Yin B, DeMicco A, Bassing CH, Diehl JA. Vaites LP, et al. Among authors: lee ek. Oncogene. 2014 Jan 2;33(1):129-33. doi: 10.1038/onc.2012.577. Epub 2013 Jan 14. Oncogene. 2014. PMID: 23318439 Free PMC article.

7

SCFs in the new millennium.

Lee EK, Diehl JA. Lee EK, et al. Oncogene. 2014 Apr 17;33(16):2011-8. doi: 10.1038/onc.2013.144. Epub 2013 Apr 29. Oncogene. 2014. PMID: 23624913 Review.

8

Breast cancer go sMAD: cyclin towards aggressive phenotypes.

Lee EK, Diehl JA. Lee EK, et al. Cell Cycle. 2011 Jan 15;10(2):187. Epub 2011 Jan 15. Cell Cycle. 2011. PMID: 21239879 No abstract available.

9

Risk of Osteoporotic Fractures among Patients with Thyroid Cancer: A Nationwide Population-Based Cohort Study.

Ku EJ, Yoo WS, Hwang YB, Jang S, Lee J, Moon S, Lee EK, Ahn HY. Ku EJ, et al. Among authors: lee ek. Endocrinol Metab (Seoul). 2025 Jan 15. doi: 10.3803/EnM.2024.2101. Online ahead of print. Endocrinol Metab (Seoul). 2025. PMID: 39814032 Free article.

10

Pediatric thyroid cancer: key considerations based on the 2024 Korean Thyroid Association Thyroid Cancer Management Guideline.

Lee EK, Lee YA. Lee EK, et al. Ann Pediatr Endocrinol Metab. 2025 Jan 6. doi: 10.6065/apem.2448296.148. Online ahead of print. Ann Pediatr Endocrinol Metab. 2025. PMID: 39757597 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,425 results

Search Page

Filters